- Home
- ELDN vs DSM Comparison
ELDN vs DSM Comparison
Compare ELDN & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- DSM
- Stock Information
- Founded
- ELDN 2004
- DSM 1989
- Country
- ELDN United States
- DSM United States
- Employees
- ELDN N/A
- DSM N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- DSM Investment Managers
- Sector
- ELDN Health Care
- DSM Finance
- Exchange
- ELDN Nasdaq
- DSM Nasdaq
- Market Cap
- ELDN 288.5M
- DSM 289.7M
- IPO Year
- ELDN N/A
- DSM N/A
- Fundamental
- Price
- ELDN $4.29
- DSM $5.99
- Analyst Decision
- ELDN Strong Buy
- DSM
- Analyst Count
- ELDN 1
- DSM 0
- Target Price
- ELDN $16.00
- DSM N/A
- AVG Volume (30 Days)
- ELDN 232.7K
- DSM 161.7K
- Earning Date
- ELDN 03-27-2025
- DSM 01-01-0001
- Dividend Yield
- ELDN N/A
- DSM 3.97%
- EPS Growth
- ELDN N/A
- DSM N/A
- EPS
- ELDN N/A
- DSM N/A
- Revenue
- ELDN N/A
- DSM N/A
- Revenue This Year
- ELDN N/A
- DSM N/A
- Revenue Next Year
- ELDN N/A
- DSM N/A
- P/E Ratio
- ELDN N/A
- DSM N/A
- Revenue Growth
- ELDN N/A
- DSM N/A
- 52 Week Low
- ELDN $1.52
- DSM $4.69
- 52 Week High
- ELDN $5.54
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- ELDN 44.28
- DSM 61.34
- Support Level
- ELDN $4.40
- DSM $5.85
- Resistance Level
- ELDN $4.65
- DSM $6.05
- Average True Range (ATR)
- ELDN 0.23
- DSM 0.05
- MACD
- ELDN -0.04
- DSM 0.01
- Stochastic Oscillator
- ELDN 8.16
- DSM 72.73
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.